The impact of haemophilus influenzae serotype B resurgence on the epidemiology of childhood invasive haemophilus influenzae disease in england and wales

Pediatric Infectious Disease Journal

Volumn 30, Issue 10, 2011, Pages 893-895

  Ladhani, Shamez N ^a   Ramsay, Mary ^a   Slack, Mary P E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

conjugate vaccine; epidemiology; Haemophilus influenzae; meningitis

Indexed keywords

ARTICLE; BACTEREMIA; CHILD; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS MENINGITIS; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; UNITED KINGDOM;

EID: 80052920156     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31822ef670     Document Type: Article

References (15)

1. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302-317. (Pubitemid 30205428)
2. Heath PT, Booy R, Azzopardi HJ, et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA. 2000;284:2334-2340.
3. Ladhani S, Slack MP, Heath PT, et al. Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom. Epidemiol Infect. 2007;135:861-867. (Pubitemid 47161672)
4. Ladhani S, Slack MP, Heys M, et al. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child. 2008;93:665-669.
5. McVernon J, Andrews N, Slack MP, et al. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet. 2003;361:1521-1523. (Pubitemid 36566346)
6. Tsang R. Capsule switching and capsule replacement in vaccine-preventable bacterial diseases. Lancet Infect Dis. 2007;7:569-570. (Pubitemid 47268220)
7. Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis. 2000;31:973-980. (Pubitemid 32299356)
8. Finn A. More lumbar punctures, please!Arch Dis Child. 2003;88:177.
9. Ihekweazu CA, Dance DA, Pebody R, et al. Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. Epidemiol Infect. 2008;136:1096-1102. (Pubitemid 351982931)
10. Ladhani S, Heath PT, Aibara RJ, et al. Long-term complications and risk of other serious infections following invasive Haemophilus influenzae sero-type b disease in vaccinated children. Vaccine. 2010;28:2195-2200.
11. Booy R, Hodgson SA, Slack MP, et al. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child. 1993;69: 225-228.
12. Moxon ER, Zwahlen A, Rubin LB. Pathogenesis of Haemophilus influen-zae meningitis: use of a rat model for studying microbial determinants of virulence. In: Sande M, Smith A, Root R, eds. Bacterial Meningitis. Edinburgh, United Kingdom: Churchill Livingstone; 1985;23-36.
13. Takala AK, Pekkanen E, Eskola J. Neonatal Haemophilus influenzae infections. Arch Dis Child. 1991;66:437-440.
14. Heath PT, Booy R, Azzopardi HJ, et al. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J. 2001;20:300-305. (Pubitemid 32240271)
15. Murphy TF, Faden H, Bakaletz LO, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28: 43-48.